Ligand Pharmaceuticals Inc (LGND.OQ)
LGND.OQ on NASDAQ Stock Exchange Global Market
47.02USD
1 Aug 2013
47.02USD
1 Aug 2013
Price Change (% chg)
$-0.36 (-0.76%)
$-0.36 (-0.76%)
Prev Close
$47.38
$47.38
Open
$48.04
$48.04
Day's High
$48.19
$48.19
Day's Low
$47.02
$47.02
Volume
2,428
2,428
Avg. Vol
77,708
77,708
52-wk High
$50.77
$50.77
52-wk Low
$14.77
$14.77
About
Ligand Pharmaceuticals Incorporated (Ligand) is a biotechnology company that operates with a business model focused on developing or acquiring assets. The Company’s technology portfolio CAPTISOL is a formulation technology that has enabled five Food and Drug Administration (FDA) approved products, including Pfizer’s VFEND IV and... (more)
Overall
| Beta: | 1.09 |
| Market Cap (Mil.): | $958.73 |
| Shares Outstanding (Mil.): | 20.23 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| LGND.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.04 | -- | -- |
| ROI: | -0.85 | -2.58 | 18.76 |
| ROE: | -2.57 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| ACADIA Pharmaceuticals Inc. (ACAD.OQ) | $19.98 | +0.28 |
| Adamis Pharmaceuticals Corp (ADMP.PK) | $0.51 | -0.01 |
| Aastrom Biosciences Inc (ASTM.OQ) | $0.41 | +0.01 |
| Akela Pharma Inc (AKL.TO) | -- | -- |
| Capstone Therapeutics Corp. (CAPS.PK) | $0.23 | +0.01 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

